Penicillamine is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Penicillamine.
| Product ID | 0591-4171_b7e1730b-faa2-4324-b7ad-d73641f652e8 |
| NDC | 0591-4171 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Penicillamine |
| Generic Name | Penicillamine |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-06-25 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA210976 |
| Labeler Name | Actavis Pharma, Inc. |
| Substance Name | PENICILLAMINE |
| Active Ingredient Strength | 250 mg/1 |
| Pharm Classes | Antirheumatic Agent [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-06-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA210976 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-06-25 |
| Ingredient | Strength |
|---|---|
| PENICILLAMINE | 250 mg/1 |
| SPL SET ID: | 594d7a82-af1d-41c4-98ee-0ea6895fc237 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0254-2000 | penicillamine | penicillamine |
| 0591-4171 | Penicillamine | Penicillamine |
| 43598-634 | Penicillamine | Penicillamine |
| 43975-309 | Penicillamine | Penicillamine |
| 49884-146 | Penicillamine | penicillamine |
| 51991-974 | Penicillamine | Penicillamine |
| 60505-4696 | Penicillamine | Penicillamine |
| 62559-970 | Penicillamine | Penicillamine |
| 68475-201 | Penicillamine | Penicillamine |
| 68682-020 | penicillamine | penicillamine |
| 70010-907 | Penicillamine | Penicillamine |
| 70748-153 | Penicillamine | Penicillamine |
| 71205-916 | Penicillamine | Penicillamine |
| 25010-705 | Cuprimine | penicillamine |
| 0378-0709 | D-Penamine | Penicillamine |
| 0037-4401 | Depen | Penicillamine |